ASRS 2024: Adverse Events With Real-World Use of Pegcetacoplan Injection for Geographic Atrophy Differ From Trial Data
Data show pegcetacoplan injection remains the preferred treatment for most physicians
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.